Search by Drug Name or NDC
NDC 00409-5255-25 Metoclopramide 5 mg/mL Details
Metoclopramide 5 mg/mL
Metoclopramide is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is METOCLOPRAMIDE HYDROCHLORIDE.
Product Information
| NDC | 00409-5255 |
|---|---|
| Product ID | 0409-5255_7552bd4f-55d2-42d2-8bf7-c0781b98fc67 |
| Associated GPIs | |
| GCN Sequence Number | 005229 |
| GCN Sequence Number Description | metoclopramide HCl VIAL 5 MG/ML INJECTION |
| HIC3 | J9A |
| HIC3 Description | INTESTINAL MOTILITY STIMULANTS |
| GCN | 20510 |
| HICL Sequence Number | 002148 |
| HICL Sequence Number Description | METOCLOPRAMIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Metoclopramide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metoclopramide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA073118 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-5255-25 (00409525525)
| NDC Package Code | 0409-5255-25 |
|---|---|
| Billing NDC | 00409525525 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-5255-25) / 2 mL in 1 VIAL, SINGLE-DOSE (0409-5255-02) |
| Marketing Start Date | 2022-11-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |